Target intelligence / Profile preview

Corneal and conjunctival epithelial surface

Molecular classification
Other, Tissue, Epithelium
01

Overview

The corneal and conjunctival epithelial surfaces represent the outermost cellular layers of the eye, serving as the primary interface between the ocular environment and the external world. This anatomical structure functions as a robust physical and immunological barrier, protecting the eye from pathogens, debris, and desiccation while maintaining the transparency and refractive power of the cornea (StatPearls, 2023, NBK470338). The conjunctival epithelium is particularly notable for its goblet cells, which secrete mucins essential for tear film stability, whereas the corneal epithelium is highly specialized for optical clarity and rapid regeneration (PubMed, PMID: 28917533). In clinical practice, this surface is the site of action for numerous topical ophthalmic medications used to treat conditions like dry eye disease and inflammation. While not a single molecular target, the health of these epithelial layers is the primary focus of ocular surface therapeutics, which aim to reduce inflammation, enhance lubrication, and promote cellular repair (NIH/NEI, 2022).

Other names
Ocular surface epitheliumCorneal epitheliumConjunctival epitheliumOcular surface
02

Mechanism of action

Topical ophthalmic drugs interact with the ocular surface by modulating inflammatory pathways (e.g., T-cell inhibition via Cyclosporine), antagonizing integrins (e.g., Lifitegrast), or providing physical lubrication and osmoprotection to stabilize the tear film and promote epithelial healing.

03

Biological functions

Barrier functionProtectionTear film stabilizationRefractionImmune surveillanceMucin secretion
04

Disease associations

Dry eye diseaseKeratoconjunctivitis siccaCorneal ulcerConjunctivitisPterygiumLimbal stem cell deficiencySjogren's syndrome
05

Safety considerations

Ocular burning and stingingBlurred visionIncreased intraocular pressure (with corticosteroid use)Delayed corneal wound healingRisk of secondary microbial infection
06

Interacting drugs

Cyclosporine

6 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)Corneal fluorescein staining scoreSchirmer's testMatrix metalloproteinase-9 (MMP-9) levelsGoblet cell densityTear osmolarity

Beyond the preview

Go deeper on Corneal and conjunctival epithelial surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal and conjunctival epithelial surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call